Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Placebo-controlled, Double-blind Trial to Evaluate the Safety and Efficacy of Infliximab in Patients With Active Ulcerative Colitis
Brief Summary: The purpose of this study is to evaluate the effectiveness and safety of infliximab (Remicade) in patients with Ulcerative Colitis. Infliximab (Remicade) targets specific proteins in the body's immune system to help control the development of inflammation to help reduce painful disease.


Options:
A: Arm Label: 1: budesonide-MMX® 6 mg; Type: EXPERIMENTAL; Interventions: Procedure: Blood sampling, endoscopy, Drug: Budesonide MMX® 6 mg | Arm Label: 2: budesonide-MMX® 9 mg; Type: EXPERIMENTAL; Interventions: Procedure: Blood sampling, endoscopy, Drug: Budesonide MMX® 9 mg | Arm Label: 3: Entocort EC® 3 mg; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Blood sampling, endoscopy, Drug: Entocort EC® 3 mg | Arm Label: 4: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Blood sampling, endoscopy, Drug: Placebo | Intervention Type: PROCEDURE; Name: Blood sampling, endoscopy; Assigned to Arm(s): 1: budesonide-MMX® 6 mg, 2: budesonide-MMX® 9 mg, 3: Entocort EC® 3 mg, 4: Placebo | Intervention Type: DRUG; Name: Budesonide MMX® 6 mg; Assigned to Arm(s): 1: budesonide-MMX® 6 mg | Intervention Type: DRUG; Name: Budesonide MMX® 9 mg; Assigned to Arm(s): 2: budesonide-MMX® 9 mg | Intervention Type: DRUG; Name: Entocort EC® 3 mg; Assigned to Arm(s): 3: Entocort EC® 3 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 4: Placebo
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: tralokinumab | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: tralokinumab; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 2
C: Intervention Type: DRUG; Name: Infliximab; Assigned to Arm(s): N/A
D: Arm Label: 0.03 mg/kg or placebo iv; Type: OTHER; Interventions: Biological: Single dose-group A | Arm Label: 0.1 mg/kg or placebo iv; Type: OTHER; Interventions: Biological: Single dose-group A, Biological: Multiple dose- Group B | Arm Label: 0.3 mg/kg or placebo iv; Type: OTHER; Interventions: Biological: Single dose-group A, Biological: Multiple dose- Group B | Arm Label: 1.0 mg/kg or placebo iv; Type: EXPERIMENTAL; Interventions: Biological: Single dose-group A | Arm Label: 3.0 mg/kg or placebo sc; Type: OTHER; Interventions: Biological: Single dose-group A | Arm Label: 10 mg/kg or placebo iv; Type: OTHER; Interventions: Biological: Single dose-group A | Arm Label: 0.3 mg/kg or placebo sc; Type: OTHER; Interventions: Biological: Single dose-group A, Biological: Multiple dose-Group B | Arm Label: 0.1 mg/kg or placebo iv (multiple dose); Type: OTHER; Interventions: Biological: Multiple dose- Group B | Arm Label: 0.3 mg/kg or placebo iv (multiple dose); Type: OTHER; Interventions: Biological: Multiple dose- Group B | Arm Label: 3.0 mg/kg or placebo iv; Type: OTHER; Interventions: Biological: Multiple dose- Group B | Arm Label: 0.1 mg/kg or placebo sc; Type: OTHER; Interventions: Biological: Multiple dose- Group B | Arm Label: 0.3 mg/kg or placebo sc (multiple dose); Type: OTHER; Interventions: Biological: Multiple dose-Group B | Intervention Type: BIOLOGICAL; Name: Single dose-group A; Assigned to Arm(s): 0.03 mg/kg or placebo iv | Intervention Type: BIOLOGICAL; Name: Single dose-group A; Assigned to Arm(s): 0.1 mg/kg or placebo iv | Intervention Type: BIOLOGICAL; Name: Multiple dose- Group B; Assigned to Arm(s): 0.1 mg/kg or placebo iv (multiple dose) | Intervention Type: BIOLOGICAL; Name: Single dose-group A; Assigned to Arm(s): 0.3 mg/kg or placebo iv | Intervention Type: BIOLOGICAL; Name: Multiple dose- Group B; Assigned to Arm(s): 0.3 mg/kg or placebo iv (multiple dose) | Intervention Type: BIOLOGICAL; Name: Single dose-group A; Assigned to Arm(s): 1.0 mg/kg or placebo iv | Intervention Type: BIOLOGICAL; Name: Single dose-group A; Assigned to Arm(s): 3.0 mg/kg or placebo sc | Intervention Type: BIOLOGICAL; Name: Single dose-group A; Assigned to Arm(s): 10 mg/kg or placebo iv | Intervention Type: BIOLOGICAL; Name: Single dose-group A; Assigned to Arm(s): 0.3 mg/kg or placebo sc | Intervention Type: BIOLOGICAL; Name: Multiple dose-Group B; Assigned to Arm(s): 0.3 mg/kg or placebo sc | Intervention Type: BIOLOGICAL; Name: Multiple dose- Group B; Assigned to Arm(s): 0.1 mg/kg or placebo iv | Intervention Type: BIOLOGICAL; Name: Multiple dose- Group B; Assigned to Arm(s): 0.3 mg/kg or placebo iv | Intervention Type: BIOLOGICAL; Name: Multiple dose- Group B; Assigned to Arm(s): 3.0 mg/kg or placebo iv | Intervention Type: BIOLOGICAL; Name: Multiple dose- Group B; Assigned to Arm(s): 0.1 mg/kg or placebo sc | Intervention Type: BIOLOGICAL; Name: Multiple dose-Group B; Assigned to Arm(s): 0.3 mg/kg or placebo sc (multiple dose)

Answer: C